EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An alignment-free strategy for circulating tumor DNA detection and tumor fraction estimation from whole-genome sequencing data

Carmen Oroperv iD, Amanda Frydendahl, Tenna Vesterman Henriksen, Giovanni Santacatterina, Alice Antonello, Nicola Calonaci, Mads Heilskov Rasmussen, Giulio Caravagna, Claus Lindbjerg Andersen iD, Søren Besenbacher iD, IMPROVE-consortia

PLOS Computational Biology · 10.08.2026 · 22 (8) · e1013356

DOI: 10.1371/journal.pcbi.1013356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 10.08.2026. Verfasst von Carmen Oroperv und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Whole Genome Sequencing, Neoplasms. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Kræftens Bekæmpelse, Associazione Italiana per la Ricerca contro il Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor DNA (ctDNA) is emerging as a promising biomarker for postoperative monitoring of cancer patients. Precise estimation of circulating tumor fraction is crucial for evaluating treatment effects and timely detection of disease recurrence. All current ctDNA detection methods that utilize whole-genome sequencing (WGS) data rely on the reference genome alignment of sequencing reads and often apply separate tools for detecting different variant types. However, various bioinformatic analysis confounders and the application of external variant calling tools could be avoided by analyzing k-mers from unaligned sequencing reads. While k-mer-based methods have successfully been applied for somatic variant validation and detection, the potential of k-mer-based ctDNA detection is unexplored. We have developed a tumor-informed alignment-free ctDNA detection tool called ctDNAmer that detects tumor-specific somatic variation directly from unaligned sequencing data by identifying k-mers unique to the tumor DNA. ctDNAmer detects variant information across the genome by comparing the primary tumor and germline WGS data and accounts for sample-specific germline variability and technical noise in the same framework. We tested the utility of ctDNAmer for tumor fraction estimation on postoperative plasma cfDNA WGS data (mean sequencing depth ~ 28x) from 90 stage III colorectal cancer patients with three years of follow-up. The tumor fraction (TF) estimates agreed with the available clinical information and ctDNA was detected in 77% (17/22) of recurring patients with a median lead time of 8 months compared to radiological imaging. We further validated ctDNAmer’s tumor fraction estimates based on a comparison with the mean cfDNA allele frequencies of somatic clonal SNVs identified from aligned primary tumor sequencing data. The TF estimates showed a strong Pearson correlation of 0.897 with the mean allele frequencies and improved ctDNA detection results across samples with an AUC of 0.79 compared to 0.75 if the mean allele frequency of clonal mutations is used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating Tumor DNAWhole Genome SequencingNeoplasmsHumansBiomarkers, TumorComputational BiologySequence Analysis, DNA

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Mathematics, Informatics and Geosciences, University of Trieste, Italy.
  • Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.

ORCID-Profile: Carmen Oroperv, Claus Lindbjerg Andersen, Søren Besenbacher

Förderung

  • Novo Nordisk Fonden
  • Kræftens Bekæmpelse
  • Associazione Italiana per la Ricerca contro il Cancro
  • AIRC Italy Post-Doc Fellowship

Zitieren

APA

Oroperv, C., Frydendahl, A., Henriksen, T. V., Santacatterina, G., Antonello, A., Calonaci, N., Rasmussen, M. H., Caravagna, G., Andersen, C. L., Besenbacher, S., & IMPROVE-consortia (2026). An alignment-free strategy for circulating tumor DNA detection and tumor fraction estimation from whole-genome sequencing data. PLOS Computational Biology, 22(8), e1013356. https://doi.org/10.1371/journal.pcbi.1013356

Vancouver

Oroperv C, Frydendahl A, Henriksen TV, Santacatterina G, Antonello A, Calonaci N, et al. An alignment-free strategy for circulating tumor DNA detection and tumor fraction estimation from whole-genome sequencing data. PLOS Computational Biology. 2026;22(8):e1013356. doi:10.1371/journal.pcbi.1013356

BibTeX
@article{Oroperv2026,
  author = {Oroperv, Carmen and Frydendahl, Amanda and Henriksen, Tenna Vesterman and Santacatterina, Giovanni and Antonello, Alice and Calonaci, Nicola and Rasmussen, Mads Heilskov and Caravagna, Giulio and Andersen, Claus Lindbjerg and Besenbacher, Søren and IMPROVE-consortia, IMPROVE-consortia},
  title = {An alignment-free strategy for circulating tumor DNA detection and tumor fraction estimation from whole-genome sequencing data},
  journal = {PLOS Computational Biology},
  year = {2026},
  volume = {22},
  number = {8},
  pages = {e1013356},
  doi = {10.1371/journal.pcbi.1013356}
}
Kostenlos starten →